Retrospective Analysis of Immune Checkpoint Inhibitors in Patients with EGFR Mutated Non-Small Cell Lung Cancer in a Japanese Cohort

被引:0
|
作者
Yamada, T. [1 ]
Shiotsu, S. [2 ]
Tanimura, K. [1 ]
Harada, T. [3 ]
Kubota, Y. [4 ]
Takeda, T. T. [5 ]
Watanabe, S. [6 ]
Uchino, J. [1 ]
Takayama, K. [1 ]
机构
[1] Kyoto Prefectural Univ Med, Kyoto, Japan
[2] Japanese Red Cross Kyoto Daiichi Hosp, Kyoto, Japan
[3] Fukuchiyama City Hosp, Fukuchiyama, Japan
[4] Japanese Red Cross Kyoto Daini Hosp, Kyoto, Japan
[5] Uji Tokushukai Med Ctr, Uji, Kyoto, Japan
[6] Niigata Univ, Grad Sch Med & Dent Sci, Dept Resp Med & Infect Dis, Niigata, Japan
关键词
EGFR mutation; immune checkpoint inhibitor;
D O I
10.1016/j.jtho.2018.08.659
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.01-102
引用
收藏
页码:S503 / S503
页数:1
相关论文
共 50 条
  • [21] Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis
    Gu, Xiaodong
    Si, Jinfei
    Guan, Yelan
    Xu, Yibing
    Shao, Lan
    Zhang, Yiping
    Xu, Chunwei
    Pan, Weiwei
    Lu, Yuanzhi
    Song, Zhengbo
    Wang, Wenxian
    OPEN MEDICINE, 2023, 18 (01):
  • [22] Analysis of immune checkpoint inhibitors for advanced non-small cell lung cancer in patients receiving antacids
    Isono, Taisuke
    Furuno, Hajime
    Onodera, Yoko
    Maruyama, Tomoya
    Takeuchi, Yuki
    Kojima, Ayaka
    Nishida, Takashi
    Kobayashi, Yoichi
    Ishiguro, Takashi
    Takaku, Yotaro
    Kurashima, Kazuyoshi
    Kagiyama, Naho
    RESPIRATORY INVESTIGATION, 2024, 62 (06) : 951 - 959
  • [23] Retrospective Efficacy Analysis of Immune Checkpoint Inhibitor Rechallenge in Patients with Non-Small Cell Lung Cancer
    Katayama, Yuki
    Shimamoto, Takayuki
    Yamada, Tadaaki
    Takeda, Takayuki
    Yamada, Takahiro
    Shiotsu, Shinsuke
    Chihara, Yusuke
    Hiranuma, Osamu
    Iwasaku, Masahiro
    Kaneko, Yoshiko
    Uchino, Junji
    Takayama, Koichi
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [24] Role of Immune Checkpoint Inhibitors (ICPi) in KRAS-Mutated Non-Small Cell Lung Cancer (NSCLC)
    Peravali, M.
    Gomes-Lima, C.
    Tefera, E.
    Baker, M.
    Sherchan, M.
    Farid, S.
    Burman, K.
    Constantinescu, F.
    Veytsman, I.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S300 - S301
  • [25] A retrospective analysis of patients with non-small cell lung cancer who developed drug-induced lung disorder by immune checkpoint inhibitors
    Hayashi, F.
    Taniguchi, H.
    Takayuki, S.
    Umeyama, Y.
    Dotsu, Y.
    Gyotoku, H.
    Senju, H.
    Takemoto, S.
    Yamaguchi, H.
    Ono, S.
    Tomono, H.
    Shimada, M.
    Soda, H.
    Fukuda, M.
    Hiroshi, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [26] Identification of Immune Checkpoint Inhibitor Therapeutic Resistance Factors in EGFR-mutated Non-Small Cell Lung Cancer
    Nakajima, Wataru
    Ishino, Kousuke
    Miyazaki, Kai
    Ohashi, Ryuji
    Yamamoto, Hayashi
    CANCER SCIENCE, 2024, 115 : 682 - 682
  • [27] Immune checkpoint inhibitors and myocarditis in advanced non-small cell lung cancer: a nationwide cohort study
    Fu-Xiao Li
    Jia-Xin Cai
    Ji-Bin Li
    Kong-Jia Luo
    Shi-Yu Wang
    Wei-Hua Meng
    Feng Sha
    Zhi-Rong Yang
    Allan Hackshaw
    Jin-Ling Tang
    Cardio-Oncology, 11 (1)
  • [28] Miliary EGFR mutated non-small cell lung cancer
    Nguyen, Mike M.
    Moore, Melissa M.
    MEDICAL JOURNAL OF AUSTRALIA, 2021, 214 (03) : 118 - 118
  • [29] Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?
    Roviello, Giandomenico
    Zanotti, Laura
    Cappelletti, Maria Rosa
    Gobbi, Angela
    Dester, Martina
    Paganini, Giovanni
    Pacifico, Chiara
    Generali, Daniele
    Roudi, Raheleh
    CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 18 (01) : 15 - 20
  • [30] Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?
    Giandomenico Roviello
    Laura Zanotti
    Maria Rosa Cappelletti
    Angela Gobbi
    Martina Dester
    Giovanni Paganini
    Chiara Pacifico
    Daniele Generali
    Raheleh Roudi
    Clinical and Experimental Medicine, 2018, 18 : 15 - 20